Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/29/2012CN102198106B Lansoprazole nano-particle frozen preparation for injection and preparation method thereof
08/29/2012CN102198065B Oral spray and preparation method thereof
08/29/2012CN102188435B Compound sulfaclozine sodium suspension and preparation method thereof
08/29/2012CN102178894B Plaster and preparation method of plaster
08/29/2012CN102139067B Quality control method for antipyretic and antitoxic tablet
08/29/2012CN102139046B Quality control method for antidotal forsythia tablet
08/29/2012CN102138910B Atorvastatin calcium tablets and preparation method thereof
08/29/2012CN102106972B Medicament for treating empyrosis and scalding and acute skin bruise and contusion, preparation method and detection method
08/29/2012CN102085179B Ibuprofen injection and preparation method thereof
08/29/2012CN102048991B Sugar-reducing comfort pill and preparation method thereof
08/29/2012CN102048925B TCM plaster used for coaptation
08/29/2012CN102028672B Microporous spongy film preparation and preparation method thereof
08/29/2012CN102008432B Sodium demethylcantharidate medicinal composition for injection and preparation method thereof
08/29/2012CN101961447B Novel preparation method, preparation and application of Chinese medicinal composition
08/29/2012CN101959501B Stabilized single-liquid pharmaceutical composition containing docetaxel
08/29/2012CN101953930B Externally-applied traditional Chinese medicine for treating tinea capitis
08/29/2012CN101947206B Method for preparing recombinant pancreotropic hormone secretion peptide medicament microspheres
08/29/2012CN101946856B Compound Chinese medicine micro powder and fish food for fish disease control
08/29/2012CN101940631B Method for preparing pollen itching-dispelling pain-relieving tincture
08/29/2012CN101940320B Preparation of medium chain fatty acid nanoliposome by using film dispersion-dynamic high-pressure microjet
08/29/2012CN101912362B Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof
08/29/2012CN101816635B Cephalosporin suspension granule and preparation method thereof
08/29/2012CN101791296B Orlistat tablets and preparation method thereof
08/29/2012CN101780172B Bacteriostatic washing liquor with high bacteriostatic action and method for preparing same
08/29/2012CN101778608B Artificial insemination device in mammal reproduction
08/29/2012CN101756991B Sustained-release pills of alfuzosin hydrochloride
08/29/2012CN101732413B Chinese medicinal composition for treating arthromyodynia and preparation method thereof
08/29/2012CN101732259B Chitosan micron particle as well as preparation method and application thereof
08/29/2012CN101653566B Chinese medicinal compound preparation for treating parotitis
08/29/2012CN101574475B Polygonatum particle and preparation method thereof
08/29/2012CN101564383B Skin external used patch
08/29/2012CN101496790B Acarbose chewable tablet
08/29/2012CN101474388B Improved prescription of Xianchan tablet medicament and preparation method thereof
08/29/2012CN101416738B Camellia essential oil soft-capsule and preparation method thereof
08/29/2012CN101401878B Chinese medicinal composition for beauty treatment and face nursing, and preparation method thereof
08/29/2012CN101365428B Disintegrating loadable tablets
08/29/2012CN101336972B Qingpeng paste and detection method thereof
08/29/2012CN101331229B Immunostimulatory oligoribonucleotides
08/29/2012CN101330907B Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
08/29/2012CN101272767B Morphous solid dispersions of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide
08/29/2012CN101190267B Medicinal composition for treating cervical vertebra disease
08/29/2012CN101181185B Cosmetic emulsions manufactured at low temperature, with low viscosity and long-term stability, with coemulgators containing cationic groups
08/29/2012CN101163796B Cationic lipids and methods of use
08/29/2012CN101084881B Targeted quick-releasing effervescence preparation and preparation method thereof
08/29/2012CN101040837B Itracomazole cream and the method for preparing the same
08/28/2012US8252901 Membrane fusion proteins derived from reovirus
08/28/2012US8252837 Tamibarotene capsule preparation
08/28/2012US8252794 Composition for regenerative treatment of cartilage disease
08/28/2012US8252776 Minocycline oral dosage forms for the treatment of acne
08/28/2012US8252747 Tissue adhesive sealant
08/28/2012US8252570 Bone delivery device
08/28/2012US8252344 Partially hydrated hemostatic agent
08/28/2012US8252339 Medical treatment applications of swellable and deformable microspheres
08/28/2012US8252338 Synthetic LDL as targeted drug delivery vehicle
08/28/2012US8252337 Charged mesoporous silica nanoparticle-based drug delivery system for controlled release and enhanced bioavailability
08/28/2012US8252336 Escitalopram and solid pharmaceutical composition comprising the same
08/28/2012US8252335 Finely powdered sucrose and a polylactic acid absorbing agent; the powder forms a cake when applied to a wound and subject to wound secretions; self-sterilizing; different viscosities to suit all kinds of wound; not painful to apply; does not disrupt the architecture of the healing wounds
08/28/2012US8252334 Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof
08/28/2012US8252333 Biodegradable, non-toxic biological adhesive for use in abdominal surgery
08/28/2012US8252332 Gastric retained gabapentin dosage form
08/28/2012US8252331 Osmotic device containing amantadine and an osmotic salt
08/28/2012US8252330 Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
08/28/2012US8252329 Bioadhesive drug formulations for oral transmucosal delivery
08/28/2012US8252328 Bioadhesive drug formulations for oral transmucosal delivery
08/28/2012US8252327 Oral controlled release dosage form
08/28/2012US8252326 Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
08/28/2012US8252325 Liposome-encapsulated glutathione for oral administration
08/28/2012US8252324 Drug delivery nanocarriers targeted by landscape phage
08/28/2012US8252323 Compositions for mucosal delivery of agents
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012US8252321 Overcoming active agent tolerance, which may be experienced from continuous administration, improve patient compliance, and in some cases reducing the amount of drug needed per dose due to advantages of biosynchronization
08/28/2012US8252320 Transdermal delivery system for sufentanil
08/28/2012US8252319 patches has pressure-sensitive adhesive matrix containing a polyisobutylene, free of permeation enhancer, for drug deliverying sufentanil through the skin to provide an analgesic effect, pain management; sustained release, side effect reduction
08/28/2012US8252318 Devices and methods for the delivery of blood clotting materials to bleeding wounds
08/28/2012US8252317 Metal alginate hydrogel and articles thereof
08/28/2012US8252312 Oral solid composition comprising a lipid absorption inhibitor
08/28/2012US8252307 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
08/28/2012US8252306 Process for preparing a semi-solid delivery vehicle comprising granisetron
08/28/2012US8252305 Methods of treating emesis utilizing semi-solid delivery pharmaceutical compositions comprising granisetron
08/28/2012US8252304 Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron
08/28/2012US8252303 A biodegradable, biocompatible polymer, a water-immiscible solvent to plasticize the polymer and form a gel, a thixotropic agent and a beneficial agent; drug delivery; improved shear thinning and reduced injection
08/28/2012US8252302 Methods and compositions to treat hemorrhagic conditions of the brain
08/28/2012US8252297 Cosmetic and dermatologic oxygen carrier system
08/28/2012US8252276 Cyclodextrin-based polymers for therapeutics delivery
08/28/2012US8252269 Impact of calcium phosphate complex on dental caries
08/28/2012US8252268 Formoterol and mometasone aerosol formulations
08/28/2012US8252046 Drug-delivery endovascular stent and method for treating restenosis
08/28/2012US8251981 Regulator
08/28/2012US8251904 Device and method for insulin dosing
08/28/2012DE202012005506U1 Fester Badezusatz mit retardiertem olfaktorischem und visuellem Freisetzungswirkungsprofil Fixed bath additive with retarded olfactory and visual release effect profile
08/28/2012CA2645724C Use of polyols to obtain stable polymorphous forms of rifaximin
08/28/2012CA2550806C Device, method and use for the formation of small particles
08/28/2012CA2529466C Ergonomic pointing device
08/28/2012CA2529290C Pharmaceutical compositions comprising peranhydrocyclodextrin
08/28/2012CA2522953C Method of measuring the efficacy of a skin treatment program
08/28/2012CA2522579C Topical formulation of ivermectin for the treatment of dermatological conditions
08/28/2012CA2514897C Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
08/28/2012CA2513746C Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
08/28/2012CA2506319C Stents comprising biodegradable polymers associated with therapeutic agents
08/28/2012CA2492470C Stable pharmaceutical composition comprising erythropoietin
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 2991